Changing the face of excipients

Dow Wolff Cellulosics is partnering with manufacturers to drive innovation and new technologies

20-Oct-2009 - Switzerland
Dow Wolff Cellulosics (DWC) will intensify its focus on the ingredient formulation and delivery needs of the Pharma market. DWC Pharma will work closely with formulators and manufacturers not only to meet existing needs, but also to drive innovation and new technologies that address emerging and future formulation and delivery challenges. “Our intention is to forge a new level of relationship with drug formulators and manufacturers, to see how they can use our expertise and know-how to address specific challenges around the delivery mechanisms of the future,” said Lucrece Foufopoulos, Global Marketing Director of DWC. “We’re approaching the market very much as a development partner.” “We’re changing the way we act, by getting closer to our customers and becoming a true solutions provider, and the way we think, by making end-user benefits a priority in our product development,“ said Martin Sonntag, General Manager of DWC. Dow Chemical’s acquisition of Wolff Walsrode in 2007 led to the Formation of DWC, which today consists of a Pharma, a Food and an Industrial Specialties business unit.

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!